Pediatrics Doctors in Montrose, CO Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Romeo Gonzaga Icasiano, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 So 5th St, Montrose, CO 81401 Phone: 870-249-2421    Fax: 970-249-8897

Thomas C Miller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 S 5th St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

Libuse K Engelbach, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 So 5th St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

Gregory Paul Suchon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 So Fifth St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

Mary Louise Vader, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 So 5th St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

Dr. Lisa Carol Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 31329 S Highway 550, Montrose, CO 81401 Phone: 254-640-5655

Thomas Dawson Wiard, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 947 S 5th St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

Dr. Teal Stephen Warthen, DO Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 947 S 5th St, Montrose, CO 81401 Phone: 970-249-2421    Fax: 970-249-8897

News Archive

Smart for Life Cookie Diet for successful weight loss

With the right weight-loss tools, consumers will be able to keep their 2010 resolutions focused on losing and maintaining a healthy weight. Dr. Sasson Moulavi, M.D. recommends the Smart for Life(R) Cookie Diet for successfully achieving and maintaining an ideal weight.

Safe and effective therapy discovered for patients with protein-losing enteropathy

Researchers at the Burnham Institute for Medical Research (Burnham Institute) have developed the first model to study intestinal protein leakage in mice, allowing the team to control and replicate both genetic deficiencies and environmental damages in an in vivo setting.

Arena agrees to sell 9,953,250 shares of common stock

Arena Pharmaceuticals, Inc. announced today that it has agreed to sell 9,953,250 shares of its common stock, at a price of $1.65775 per share, and approximately 9,953 shares of its Series D Convertible Preferred Stock, at a price of $1,657.75 per share, in a registered direct public offering to entities affiliated with Deerfield Management, a healthcare investment organization.

CircusFit, Ringling Bros, HOPSports announce new partnership to encourage kids to stay active, healthy

Ringling Bros. CircusFit and HOPSports announce new partnership that will allow children around the world to get physically fit while having fun. CircusFit will be powered by the HOPSports Training System combining circus skills with state of the art technology to encourage youth to stay active and healthy.

Read more Medical News

› Verified 6 days ago